Moderna to open vaccine facility in Laval in 2024 – CBC
Facility will manufacture mRNA vaccines and employ at least 200
Aug 11, 2022
Moderna says construction of its new mRNA vaccine factory in Laval, Que. will begin later this year, with production expected to begin by the end of 2024.
It will be the pharmaceutical giant’s first manufacturing facility outside the United States and cost an estimated $180 million to construct.
Moderna says it has agreed to purchase land in the Montreal suburb’s biotechnology park, to serve as the site of its biomanufacturing facility.
The Massachusetts-based company says the site is ideal because it is home to a campus of a renowned Quebec research institute, the Institut National de la Recherche Scientifique (INRS).
Moderna announced in April that it would build a factory in the Montreal area that would produce about 30 million vaccine doses a year, with the ability to ramp up production to 100 million a year should there be a need.
Read more: https://www.cbc.ca/news/canada/montreal/moderna-vaccine-facility-laval-1.6548396
